In addition to personal injury and wrongful death lawsuits pending over Medtronic’s Infuse bone graft device, the company is now facing heat from its shareholders, who filed a securities fraud lawsuit against the company over allegations that they artificially inflated stock prices with dangerous off-label promotional schemes.
Thomas J. Henry are leaders in the area of product liability litigation. Our Defective Drug and Products Division has extensive knowledge and resources in order to represent our clients efficiently and aggressively.
Your choice does matter. If you or a loved one has suffered serious injuries because of Medtronic’s Infuse, call the Thomas J. Henry immediately. We are available 24/7, nights and weekends.